|
Preobrazhenskaia D.V., Kremplevskaya S.P., Muzyka A.D., Melekhina E.V.
Features of the course of respiratory mycoplasmosis in children in the postcovid period
|
№4 / 2023
|
|
Davidova N.G., Ugleva S.V., Akimkin V.G.
Risk factors for unfavorable course of COVID-19 in a prediction model in residents of long-term care facilities
|
№4 / 2023
|
|
Vorobyeva O.V., Lastochkin A.V., Gimaldinova N.E., Romanova L.P., Yusov A.A.
Lung and liver changes during covid-19 infection in the presence of liver cirrhosis
|
№4 / 2020
|
|
Vorobyeva O.V., Lastochkin A.V.
A clinical and morphological case of COVID-19
|
№2 / 2020
|
|
Khavkina D.A., Ruzhentsova Т.А., Chukhlyaev P.V., Garbuzov А.А., Shushakova E.K.
Role of disintoxication and antioxidant therapy for COVID-19: theory and practice
|
№2 / 2020
|
|
Vengerov Yu.Ya., Nagibina M.V., Ryzhov G.E., Krasnova S.V., Tsvetkova N.А., Smirnova T.Yu., Svistunova T.S., Matosovа S.V., Kulagina M.G., Kovalenko T.M.
Pneumonia as a clinical form of meningococcal infection caused by serogroup W meningococcus
|
№1 / 2020
|
|
Zaitsev A.A., Akimkin V.G., Briko N.I.
Vaccines for the prevention of pneumococcal infections: a case study of adults from organized collectives
|
№4 / 2018
|
|
Andreeva I.V., Stetsiouk O.U., Kozlov R.S.
Current approaches to the specific prevention of pneumococcal infection: Whom, when, what?
|
№5 / 2015
|
|
Briko N.I.
Vaccination is a decisive measure to reduce the burden associated with infectious diseases among adults
|
№4 / 2013
|
|
Akimkin V.G., Briko N.I., Malinovsky V.V., Korotchenko S.I., Alimov A.V., Kochetkov A.V., Volgin A.R., Shevtsov V.A., Mosyagin V.D., Kryzhanovsky V.G.
Clinical and epidemiological characteristics of (Group A) streptococcal infection in military collective bodies
|
№2 / 2011
|
Русский
